This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Here's Why Hold Strategy is Apt for Centene (CNC) Stock
by Zacks Equity Research
Riding on its inorganic growth story and 2021 guidance, Centene (CNC) holds enough potential to reap benefits for investors.
Centene (CNC) to Aid Eligible Medicaid Members in Hawaii
by Zacks Equity Research
Centene's (CNC) new agreement intends to improve health outcomes for eligible Medicaid and CHIP members of Hawaii.
The Zacks Analyst Blog Highlights: Pfizer, UnitedHealth Group, Centene Corp, Cigna Corp and AMN Healthcare Services
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pfizer, UnitedHealth Group, Centene Corp, Cigna Corp and AMN Healthcare Services
4 Stocks That Continue to Gain From Telehealth Offerings
by Zacks Equity Research
We take a sneak peek into four telehealth stocks that are well-poised for growth on their robust digital services suite.
Anthem (ANTM) to Buy myNEXUS to Boost Homehealth Business
by Zacks Equity Research
Anthem (ANTM) to purchase at-home provider, benefits coordinator, myNEXUS, to provide better in-home care.
Centene (CNC) vs. Humana (HUM): Which is Better-Positioned?
by Zacks Equity Research
Centene (CNC) and Humana (HUM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which stock is more profitable based on fundamentals.
Humana (HUM), Mercy Tie Up to Extend Telehealth Services
by Zacks Equity Research
Humana (HUM) partners with Mercy to expand virtual care services for members.
Centene's (CNC) Hawaii Arm to Keep Offering Healthcare Services
by Zacks Equity Research
Centene's (CNC) Hawaii subsidiary 'Ohana Health Plan is selected to continue catering services via the CSS plan.
Community Health's (CYH) Q4 Earnings Surpass, Improve Y/Y
by Zacks Equity Research
Community Health's (CYH) fourth-quarter earnings gain from lower costs. However, the same is offset to some extent by soft admissions.
XPO Logistics, Centene, Pinterest, Facebook and Twitter highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
XPO Logistics, Centene, Pinterest, Facebook and Twitter highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Centene (CNC)
by Madeleine Johnson
This healthcare plan provider is hoping some recent acquisitions will kick start its recovery after a difficult 2020.
Magellan Health (MGLN), Wellth Tie Up on Behavioral Change
by Zacks Equity Research
Magellan Health (MGLN) initiates a pilot program with Wellth to improve medication adherence and the general health of its members.
Company News for Feb 10, 2021
by Zacks Equity Research
Companies In The News Are: CNC, HMC, SPGI, MLM.
Centene (CNC) Q4 Earnings Surpass Estimates, Tumble Y/Y
by Zacks Equity Research
Centene (CNC) Q4 results gain from improved revenues as well as better membership.
Centene (CNC) Tops Q4 Earnings Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of 2.22% and -0.65%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Centene (CNC) This Earnings Season?
by Zacks Equity Research
Centene's (CNC) Q4 results are likely to reflect escalating costs and other COVID-related factors.
Analysts Estimate Centene (CNC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why is it Advisable to Hold on to Cigna (CI) Stock Now?
by Zacks Equity Research
Cigna (CI) looks poised to grow on the back of business rejig, which involves growing its healthcare business while lowering debt.
Here's Why You Should Steer Clear of Centene (CNC) Stock Now
by Zacks Equity Research
Rising costs and poor financial leverage make Centene (CNC) an unattractive stock now.
ETFs to Gain on UnitedHealth and Change Healthcare Deal
by Sweta Killa
UnitedHealth agreed to buy Change Healthcare for $7.84 billion in cash.
Centene (CNC) to Buy Magellan Health for Better Medical Care
by Zacks Equity Research
Centene (CNC) to acquire Magellan Health for providing better healthcare to the most susceptible and underserved communities.
New Strong Sell Stocks for January 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Company News for Jan 5, 2021
by Zacks Equity Research
Companies in The News are: HLF,MGLN,CNC,WKHS,FLIR,TDY
Magellan Health (MGLN) Buys Bayless to Aid Behavioral Health
by Zacks Equity Research
Magellan Health (MGLN) purchases a majority stake in Bayless Integrated Healthcare to bolster/evolve its collaborative care strategy.
Centene (CNC) Announces Solid Financial Guidance for 2021
by Zacks Equity Research
Centene (CNC) provides an impressive 2021 guidance for key metrics owing to its strong inorganic growth story and a healthy revenue stream.